Myoblast-mediated gene transfer to the joint

Journal of Orthopaedic Research

Volumn 15, Issue 6, 1997, Pages 894-903

  Day, C S ^a   Kasemkijwattana, C ^a   Menetrey, J ^a   Floyd S S , Jr ^a   Booth, D ^a   Moreland, M S ^a   Fu, F H ^a   Huard, J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; JOINTS (ANATOMY); LIGAMENTS; MUSCLE; PROTEINS;

MYOBLASTS;

GENETIC ENGINEERING;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; MYOBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RABBIT; SYNOVIOCYTE;

EID: 0031278166     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100150616     Document Type: Article

References (39)

1. 1 Acsadi G, Jani A, Huard J, Blaschuk K, Massie B, Holland P, Lochmuller H, Karpati G: Cultured human myoblasts and myotubes show markedly different transducibility by replication‐defective adenovirus recombinant. Gene Ther 1: 338–340, 1994
2. 2 Alameddine HS, Fardeau M: Muscle reconstruction by satellite cell grafts. J Neural Sci 98: 126, 1990
3. 3 Bandara G, Mueller GM, Galea‐Lauri J, Tindal MH, Georgescu HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD, Evans CH: Intraarticular expression of biologically active interleukin 1‐receptor‐antagonist protein by ex vivo gene transfer. Proc Nact Acad Sci U S A 90: 10764–10768, 1993
4. 4 Booth DK II, Floyd SS Jr, Day CS, Glorioso JC, Kovesdi I, Huard J: Myoblast mediated ex vivo gene transfer to mature muscle. Tissue Eng 3: 125–133, 1997
5. 5 Dai Y, Roman M, Naviaux RK, Verma IM: Gene therapy via primary myoblasts: long‐term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 89: 10892–10895, 1992
6. 6 Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM: Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254: 1509–1512, 1991
7. 7 Doherty PJ: Gene therapy and arthritis. J Rheumatol 22: 1220–1223, 1995
8. 8 Dunckley MG, Love DR, Davies KE, Walsh FS, Morris GE, Dickson G: Retroviral‐mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. FEBS Lett 296: 128–134, 1992
9. 9 Evans C, Robbins PD: Prospects for treating arthritis by gene therapy. J Rheuniatol 21: 779–782, 1994
10. 10 Evans CH, Robbins PD: Current concepts review. Possible orthopaedic applications of gene therapy. J Bone Joint Surg [Am] 77: 1103–1114, 1995
11. 11 Evans CH, Robbins PD: Progress toward the treatment of arthritis by gene therapy. Ann Med 27: 543–546, 1995
12. 12 Floyd SS Jr, Clemens PR, Ontell MR, Kochanek S, Day CS, Yang J, Hauschka SD, Morgan J, Feero GW, Epperly M, Huard J: Ex vivo gene transfer using adenovirus mediated full‐length dystrophin delivery to mature dystrophic muscles. Unpublished data
13. 13 Georgescu HI, Mendelow D, Evans CH: HIG‐82: an established cell line from rabbit periarticular soft tissue, which retains the “activatable” phenotype. In Vitro Cell Dev Biol 24: 1015–1022, 1988
14. 14 Gerich TG, Fu FH, Robbins PD, Evans CH: Prospects for gene therapy in Sports medicine. Knee Surg, Sports Traumatol Arthroscopy 4: 180–187, 1996
15. 15 Gibson AJ, Karasinski J, Relvas J, Moss J, Shcrratt TG, Strong PN, Watt DJ: Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle. J Cell Sci 106: 207–214, 1995
16. 16 Grinnell AD: Trophic interaction between nerve and muscle. In: Myology ed 2, pp 303–304. Ed by AG Engel and C Franzini‐Armstrdng. New York, McGraw‐Hill, 1994
17. 17 Gussoni E, Pavlath GK, Lanctot AM, Sharma K, Miller RG, Steinman L, Blau HM: Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356: 435–438, 1992
18. 18 Huard J, Bouchard JP, Roy R, Malouin F, Dansereau G, Labrecque C, Albert N, Richards CL, Lemieux B, Tremblay JP: Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 15: 550–560, 1992
19. 19 Huard J, Roy R, Bouchard JP, Malouin F, Richards CL, Tremblay JP: Human myoblast transplantation between imnuinohistocompatible donors and recipients produces immune reactions. Transplant Proc 6: 3049–3051, 1992
20. 20 Huard J, Acsadi G, Jani A, Massie B, Karpati G: Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 5: 949–958, 1994
21. 21 Huard J, Verjreault S, Roy R, Tremblay M, Tremblay JP: High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest 93: 586–599, 1994
22. 22 Huard J, Goins WF, Glorioso JC: Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Ther 2: 385–392, 1995
23. 23 Huard J, Akkaraju G, Watkins SC, Pike‐Cavalcoli M, Glorioso JC: LacZ gene transfer to skeletal muscle using a replicationdefective herpes simplex virus type 1 mutant vector. Hum Gene Ther 4: 439–452, 1997
24. 24 Jiao S, Schultz E, Wolff JA: Intracerebral transplants of primary muscle cells: a potential “platform” for transgene expression in the brain. Brain Res 575: 143–147, 1992
25. 25 Jiao S, Williams P, Safda N, Schultz E, Wolff JA: Cotransplantation of plasmid‐transfected myoblasts and myotubes into rat brains enables high levels of gene expression long‐term. Cell Transplant 2: 185–192, 1993
26. 26 Karpati G, Ajdukovic D, Arnold D, Gledhill RB, Guttmann R, Holland P, Koch PA, Shoubridge E, Spence D, Vanasse M, Walters GV, Abrahmowicz M, Duff C, Worton RG: Myoblast transfer in Duchenne Muscular Dystrophy. Ann Neurol 34: 8–17, 1993
27. 27 Labrecque C, Huard J, Dansereau G, Robitaille L, Tremblay JP: A new technique to identify hybrid myotubes in vitro without culture fixation. J Histochem Cytochem 39: 139–143, 1991
28. 28 Lau HT, Yu M, Fontana A, Stoeckert CJ Jr: Prevention of islet allograft rejection with engineered myoblasts expressing fas in mice. Science 273: 109–111, 1996
29. 29 Law PK, Goodwin TG, Fang Q, Chen M, Li HJ, Fiorendo A, Kirby D, Bertorini T, Herrod H, Golden G: Pioneering development of myoblast transfer therapy. In: Muscular Dystrophy Research: Excerpta Medica International Congress Series 934, pp 109–116. Ed by C Angclinu, GA Danieli, and D Fontanari. New York, Elsevier, 1991
30. 30 Lynch CM, Clowes MM, Osborne WRA. Clowes AW, Miller AD: Long‐term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy. Proc Natl Acad Sci USA 89: 1138–1142, 1992
31. 31 Morgan JE, Beauchamp JR, Pagel CN, Pecknam M, Ataliotis P, Jat PS, Noble MD, Farmer K, Partridge TA: Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue‐specific and mutation‐specific cell lines. Dev Biol 162: 486–498, 1994
32. 32 Nita I, Ghivizzani SC, Galea‐Lauri J, Bandara G, Georgescu HI, Robbins PD, Evans CH: Direct gene delivery to synovium: an evaluation of potential vectors in vitro and in vivo, Arthritis Rheum 39: 82O–828, 1996
33. 33 Salvatori G, Ferrari G, Mezzogiorno A, Scrvidei S, Coletta M, Tonalli P, Giavassi R, Cossu G, Mavilio F: Retroviral vectormediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. Hum Gene Ther 4: 713–723, 1993
34. 34 Sanes JR, Rubenstein JLR, Nicolas JF: Use of a recombinant retrovirus to study post‐implantation cell lineage in mouse embryos. EM BO J 5: 5133–5142, 1986
35. 35 Satoh A, Huard J, Labrecque C, Tremblay JP: Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts. J Histochem Cytochem 41: 1579–1582, 1993
36. 36 Simonson GD, Groskreutz DJ, Gorman CM, MacDonald MJ: Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Hum Gene Ther 7: 71–78, 1996
37. 37 Stewart M: Intermediate filaments: structure, assembly and molecular interactions. Curr Opin Cell Biol 2: 91–100, 1990
38. 38 Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL: Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular transplantation. Cell Transplant 2: 99–112, 1993
39. 39 Vandenburgh H, Del Tatto M, Shansky J, Lemaire J, Chang A, Payumo F, Lee P, Goodyear A, Raven L: Tissue‐engineered skeletal muscle organoids for reversible gene therapy. Hum Gene Ther 7: 2195–2200, 1996